Definitive Healthcare Corp. (DH) — Financial statements
Income statement, balance sheet, and cash flow for Definitive Healthcare Corp. — annual and quarterly history with growth and margin analysis.
| Metric (USD Millions) | 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|---|
| Revenue & Gross Profit | ||||||
| Revenue | 242↓4.2% | 252↑0.3% | 251↑12.9% | 223↑34.0% | 166 | |
| Cost of Revenue | 58↑6.4% | 55↑15.3% | 47↑11.4% | 43↑4.8% | 41 | |
| Gross Profit | 183↓7.2% | 197↓3.2% | 204↑13.3% | 180↑43.5% | 125 | |
| Operating Expenses | ||||||
| R&D Expenses | 35↓4.8% | 37↓14.0% | 42↑21.6% | 35↑87.9% | 19 | |
| General & Administrative Expenses | 52↑4.8% | 49↓16.3% | 59↑14.2% | 52↑56.9% | 33 | |
| Selling & Marketing Expenses | 82↓2.6% | 84↓11.3% | 95↑5.5% | 90↑58.9% | 56 | |
| SG&A Expenses | 133↑0.1% | 133↓13.2% | 153↑8.7% | 141↑58.1% | 89 | |
| Other Expenses | 36↓95.2% | 739↑118.6% | 338↑603.4% | 48↑6.8% | 45 | |
| Operating Expenses | 204↓77.6% | 908↑70.2% | 534↑138.2% | 224↑46.7% | 153 | |
| Total Costs & Expenses | 262↓72.8% | 963↑65.7% | 581↑117.9% | 267↑37.8% | 193 | |
| Operating Results | ||||||
| Operating Income | -21↑97.1% | -711↓115.5% | -330↓648.8% | -44↓61.2% | -27 | |
| Depreciation & Amortization | 36↓30.7% | 52↓0.2% | 52↓9.1% | 57↓5.1% | 60 | |
| EBITDA | -162↑71.4% | -567↓135.1% | -241↓1019.8% | 26↑13.6% | 23 | |
| EBIT | -198↑68.0% | -619↓111.2% | -293↓855.0% | -31↑16.8% | -37 | |
| Interest & Other Income | ||||||
| Net Interest Income | -4↓1670.2% | -0.25↑84.3% | -2↑81.5% | -8↑67.5% | -26 | |
| Interest Income | 7↓52.4% | 15↑6.9% | 14↑389.6% | 3↑9510.3% | 0.03 | |
| Interest Expense | 11↓23.9% | 15↓2.4% | 15↑35.7% | 11↓56.8% | 26 | |
| Non-Operating Income | 177↑293.0% | -92↓149.6% | -37↓175.5% | -13↓240.0% | 10 | |
| Other Income / Expenses | -189↓344.8% | 77↑256.5% | 22↑898.2% | 2↑106.1% | -35 | |
| Income Before Tax | -209↑67.0% | -634↓105.6% | -308↓635.9% | -42↑33.3% | -63 | |
| Income Tax Expense | -10↑76.5% | -42↓128.0% | -19↓4.8% | -18↓3895.0% | -0.44 | |
| Net Income & EPS | ||||||
| Net Income from Continuing Operations | -199↑66.3% | -591↓104.2% | -290↓1097.8% | -24↑61.2% | -62 | |
| Net Income from Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Net Income | -139↑66.4% | -413↓104.1% | -202↓2702.4% | -7↑86.1% | -52 | |
| Bottom-Line Net Income | -139↑66.4% | -413↓104.1% | -202↓2702.4% | -7↑59.5% | -18 | |
| EPS (Basic) | -1.30↑63.3% | -3.54↓97.8% | -1.79↓2407.0% | -0.07↑62.4% | -0.19 | |
| EPS (Diluted) | -1.30↑63.3% | -3.54↓97.8% | -1.79↓2407.0% | -0.07↑62.4% | -0.19 | |
| Weighted Average Shares | 107↓8.6% | 117↑3.4% | 113↑11.5% | 101↑4.2% | 97 | |
| Weighted Average Diluted Shares | 107↓8.6% | 117↑3.4% | 113↑11.5% | 101↑4.2% | 97 | |
* All figures in Millions of USD, except per share data. Growth rates calculated Year-over-Year (YoY). Data source: SEC Filings.